CTI BioPharma Corp (CTIC)

1.24 -0.01  -0.80% NASDAQ Feb 20, 16:59 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
03/13/2020 Earnings CTI BioPharma Corp Fourth Quarter Earnings Results in 2019
11/04/2019 Earnings CTI BioPharma Corp Third Quarter Earnings Results for 2019
08/01/2019 Earnings CTI BioPharma Corp Second Quarter Earnings Results in 2019
05/16/2019 10:00 PDT Misc CTI BioPharma Corp Annual General Meeting in 2018
05/02/2019 Earnings CTI BioPharma Corp First Quarter Earnings Results in 2019
03/13/2019 Earnings CTI BioPharma Corp Fourth Quarter Earnings Results in 2018
03/13/2019 Misc CTI BioPharma Corp Annual Report in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.ctibiopharma.com
  • Investor Relations URL: http://investors.ctibiopharma.com/phoenix.zhtml?c=92775&p=irol-irhome
  • HQ State/Province: Washington
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Mar. 13, 2020
  • Last Earnings Release: Nov. 04, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. The company's therapeutic area is blood-related cancers. Its products under pipeline include PIXUVRI, and Pacritinib. PIXUVRI is a novel aza-anthracenedione with unique structural and physiochemical properties. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.